<DOC>
	<DOCNO>NCT00043342</DOCNO>
	<brief_summary>The purpose research study evaluate safety , tolerability , efficacy Interferon gamma-1b ( IFN-gamma 1b ) administer subcutaneous injection period 4 week patient mild-to-moderate cystic fibrosis . Additionally , preliminary assessment effect IFN-gamma 1b lung function indicator health make .</brief_summary>
	<brief_title>Study Interferon Gamma-1b Injection Treatment Patients With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-gamma</mesh_term>
	<criteria>At least 6 year age Diagnosis cystic fibrosis ( certain criterion ) Able perform pulmonary ( lung ) function test participate induce sputum procedure Pulmonary function value must meet certain minimal requirement Must acceptable laboratory test result Can certain medication immediately prior study Can history unstable deteriorate cardiac neurologic disease</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>pulmonary impairment</keyword>
</DOC>